Prestige News

Total 80
Number Thumbnail Title Author Date Votes Views
50 Prestige Biopharma IDC Files Patent for Bispecific Antibody Targeting Cytokine Storm–Related Inflammatory Diseases
김** | 2026.02.24 | Votes 0 | Views 1890
김** 2026.02.24 0 1890
49 Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
김** | 2026.01.29 | Votes 0 | Views 1747
김** 2026.01.29 0 1747
48 Prestige Biopharma IDC Files Patent for PBP1710 Targeting Fibrotic Diseases
김** | 2026.01.23 | Votes 0 | Views 1750
김** 2026.01.23 0 1750
47 Prestige Biopharma Secures U.S. Patent for Novel Anticancer Antibody PBP1710
김** | 2025.12.08 | Votes 0 | Views 1827
김** 2025.12.08 0 1827
46 Prestige Biopharma IDC Selected for National Drug Development Project for TNBC Program
김** | 2025.11.25 | Votes 0 | Views 1902
김** 2025.11.25 0 1902
45 Prestige Biopharma Secures Herceptin Biosimilar Supply Deal in South America
김** | 2025.11.24 | Votes 0 | Views 1987
김** 2025.11.24 0 1987
44 Busan Mayor Visits Prestige Biopharma IDC to Support Regional Bioindustry Growth
김** | 2025.11.05 | Votes 0 | Views 1518
김** 2025.11.05 0 1518
43 Prestige Biopharma Presents PAUF-Based Pancreatic Cancer Program at ESMO 2025
we******** | 2025.10.21 | Votes 0 | Views 1609
we******** 2025.10.21 0 1609
42 Prestige Biopharma IDC Files Patent for Sustained-Release Subcutaneous Delivery Platform for High-Concentration Protein Therape
김** | 2025.10.14 | Votes 0 | Views 1743
김** 2025.10.14 0 1743
41 Prestige Biopharma IDC Publishes IHC-Based PAUF Diagnostic Platform Study in International Journal
we******** | 2025.09.17 | Votes 0 | Views 1438
we******** 2025.09.17 0 1438